Perphenazine is a D2DR inhibitor which inhibits the glutamate dehydrogenase in vitro. Perphenazine also acts as a α-adrenergic receptor antagonist and σ-receptor agonist. Studies indicate that uncharged Perphenazine is better at forming complexes with cyclodextrins. In addition, Perphenazine forms more stable complexes with cyclodextrins than fluphenazine (sc-205700). Studies show that Perphenazine enhances the expression of CD71 on K562 cells, while at the same time inhibiting the proliferation of these cells.
1. Lutka, A. and Prange, W. 2005. Acta Pol Pharm. 62: 419-425. PMID: 16583980 2. Yuan, L.B. and He, Q. 2005. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 30: 288-291. PMID: 16045015
Soluble in Chloroform and Methanol
Store at 4° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Download SDS (MSDS)
Certificate of Analysis
Adobe Acrobat Reader is required to reliably view, print and comment on PDF documents
What is the appearance of the compound?
Asked by: two2igm05
Thank you for your question. The compound, sc-208161, is provided as a white to off-white powder. If you have any further questions or concerns, please feel free to contact our Technical Service department by calling 800-457-3801 option 2, emailing [email protected], or using the Live Chat function on our website.
Rated 5 out of
Yuan et alYuan et al. (PubMed ID 16045015) found that perphenazine promoted the expression of CD71 and increased Hb content in K562 cells, while inhibiting the proliferation of K562 cells. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn